Related Experiment Video

Updated: May 28, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells

Xin-Ke Zhou1, Sheng-Song Tang, Gao Yi

  • 1Department of Pharmacology, University of South China, Hengyang 421001, Hunan Province, China.

World Journal of Gastroenterology
|October 13, 2011
PubMed
Abstract

Insights

Silencing PIK3CA with siRNA reduced gastric cancer cell proliferation, migration, and invasion. This targeted approach shows potential for gastric cancer therapy by inhibiting PIK3CA expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The PIK3CA gene is frequently mutated in various cancers, including gastric cancer.
  • PIK3CA mutations are associated with increased cell proliferation, migration, and invasion.
  • Targeting PIK3CA offers a potential therapeutic strategy for gastric cancer.

Purpose of the Study:

  • To investigate the effects of PIK3CA silencing using siRNA on gastric cancer cell behavior.
  • To explore the underlying molecular mechanisms, including Akt phosphorylation.
  • To assess the therapeutic potential of PIK3CA targeting in gastric cancer.

Main Methods:

  • Screening of PIK3CA mutations in gastric cancer cell lines (HGC-27, SGC-7901, BGC-823, MGC-803, MKN-45) using PCR and sequencing.
  • In vitro transfection of siRNA targeting PIK3CA into BGC-823 (wild-type) and HGC-27 (mutant) cells.
  • Quantification of PIK3CA mRNA and protein expression via real-time PCR and Western blotting.
  • Assessment of Akt phosphorylation using Western blotting.
  • Evaluation of cell proliferation, migration, and invasion using MTT, wound healing, and Transwell assays.

Main Results:

  • siRNA-mediated PIK3CA silencing effectively reduced PIK3CA mRNA and protein levels.
  • Down-regulation of PIK3CA significantly inhibited Akt phosphorylation (P < 0.05).
  • PIK3CA knockdown markedly decreased gastric cancer cell proliferation, migration, and invasion (P < 0.01).
  • Mutant HGC-27 cells showed higher invasion than wild-type BGC-823 cells.
  • PIK3CA knockdown in HGC-27 cells led to a greater reduction in invasion compared to BGC-823 cells.

Conclusions:

  • siRNA targeting of PIK3CA specifically reduces its expression in gastric cancer cells.
  • This targeted silencing demonstrates significant anti-proliferative, anti-migratory, and anti-invasive effects.
  • Targeting PIK3CA via siRNA presents a promising therapeutic strategy for gastric cancer treatment.
Keywords:
Gastric cancerMetastasisPI3K/Akt pathwayPIK3CARNAi

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...